Registered entities
AIMMUNE THERAPEUTICS, INC.
Reg. No. 1631650United States
Aimmune Therapeutics, Inc.
Reg. No. 001t000000WoWoyAAFUnited States
AIMMUNE THERAPEUTICS, INC.
Reg. No. 5552964United States
AIMMUNE THERAPEUTICS UK LIMITED
Reg. No. 9559128United Kingdom
Innovation
17 patent families (6 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 981 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 8 |
| 2020 | 12 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 1 |
Investor mix
11 investors on record; lead investors include RA Capital Management; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 9% |
| Private equity | 5 | 45% |
| Other / undisclosed | 5 | 45% |